Safety and Efficacy of Pagibaximab Injection in Very Low Birth Weight Neonates for Prevention of Staphylococcal Sepsis
Clinical trial NCT00646399 · COMPLETED
Trial details
- NCT number
- NCT00646399
- Sponsor
- Biosynexus Incorporated
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-03-01
- Primary completion
- 2011-05-01
- Enrollment
- 1579
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.